Engineering Proteins for Cell Entry
Molecular Pharmaceutics · 2023
DOI: 10.1021/acs.molpharmaceut.3c00467 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Pharmaceutics, 2023. Verfasst von Xiaoyu Feng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, Ch…. Hauptthemen laut MEDLINE: Protein Engineering, Cell-Penetrating Peptides. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 142 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Double First Class University Plan, National Natural Science Foundation of China.
Abstract (Originalsprache)
Proteins are essential for life, as they participate in all vital processes in the body. In the past decade, delivery of active proteins to specific cells and organs has attracted increasing interest. However, most proteins cannot enter the cytoplasm due to the cell membrane acting as a natural barrier. To overcome this challenge, various proteins have been engineered to acquire cell-penetrating capacity by mimicking or modifying natural shuttling proteins. In this review, we provide an overview of the different types of engineered cell-penetrating proteins such as cell-penetrating peptides, supercharged proteins, receptor-binding proteins, and bacterial toxins. We also discuss some strategies for improving endosomal escape such as pore formation, the proton sponge effect, and hijacking intracellular trafficking pathways. Finally, we introduce some novel methods and technologies for designing and detecting engineered cell-penetrating proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Druggability of Biopharmaceuticals and State Key Laboratory of Natural Medicines, School of Life Science and Technology, China Pharmaceutical University, Nanjing 210009, China.
- Department of Clinical Laboratory, Beijing Jishuitan Hospital Guizhou Hospital, No. 206, Sixian Street, Baiyun District, Guiyang, Guizhou 550014, China.
- Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing 210009, China.
ORCID-Profile: Jun Yin
Förderung
- Natural Science Foundation of Jiangsu Province
- Double First Class University Plan
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Feng, X., Chang, R., Zhu, H., Yang, Y., Ji, Y., Liu, D., Qin, H., Yin, J., & Rong, H. (2023). Engineering Proteins for Cell Entry. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.3c00467
Vancouver
Feng X, Chang R, Zhu H, Yang Y, Ji Y, Liu D, et al. Engineering Proteins for Cell Entry. Molecular Pharmaceutics. 2023. doi:10.1021/acs.molpharmaceut.3c00467
BibTeX
@article{Feng2023,
author = {Feng, Xiaoyu and Chang, Ruilong and Zhu, Haichao and Yang, Yifan and Ji, Yue and Liu, Dingkang and Qin, Hai and Yin, Jun and Rong, Haibo},
title = {Engineering Proteins for Cell Entry},
journal = {Molecular Pharmaceutics},
year = {2023},
doi = {10.1021/acs.molpharmaceut.3c00467}
}
EUVIMED